{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:52:06Z","timestamp":1792291926765,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cbi.2022.110048","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T01:30:44Z","timestamp":1659576644000},"page":"110048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems"],"prefix":"10.1016","volume":"365","author":[{"given":"Parteek","family":"Prasher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousmee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Zacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha","family":"de Jesus Andreoli Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Gregory","family":"George Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110048_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2022.110048_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/JIR.S271292","article-title":"Cytokine storm and mucus hypersecretion in COVID-19: review of mechanisms","volume":"14","author":"Khan","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cbi.2022.110048_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2020.10.031","article-title":"Advanced materials for drug delivery across mucosal barriers","volume":"119","author":"Bandi","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.cbi.2022.110048_bib5","first-page":"275","article-title":"Developments of mucus penetrating nanoparticles","volume":"10","author":"Liu","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating drug delivery","volume":"98","author":"Netsomboom","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","article-title":"Engineering the mucus barrier","volume":"20","author":"Carlson","year":"2018","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.cbi.2022.110048_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jddst.2015.12.002","article-title":"Recent advances in mucoadhesive floating drug delivery systems: a mini review","volume":"31","author":"Patil","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.cbi.2022.110048_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/03639045.2017.1294600","article-title":"A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems","volume":"43","author":"da Silva","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425247.2021.1854222","article-title":"Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung","volume":"18","author":"Chen","year":"2021","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.cbi.2022.110048_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","article-title":"The biology of mucus: composition, synthesis and organization","volume":"124","author":"Bansil","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2022.110048_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery: understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2022.110048_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro-and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2022.110048_bib14","article-title":"Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses","volume":"9","author":"Beule","year":"2010","journal-title":"GMS Curr. Top. Otorhinolaryngol., Head Neck Surg."},{"key":"10.1016\/j.cbi.2022.110048_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1515\/ejnm-2014-0019","article-title":"Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics","volume":"6","author":"Murgia","year":"2014","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.cbi.2022.110048_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.bpj.2013.07.050","article-title":"Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier","volume":"105","author":"Li","year":"2013","journal-title":"Biophys. J."},{"key":"10.1016\/j.cbi.2022.110048_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj2390147","article-title":"Electron microscopy of cervical, gastric and bronchial mucus glycoproteins","volume":"239","author":"Sheehan","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2022.110048_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cbi.2022.110048_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2022.110048_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nano10020183","article-title":"Multifunctional nanocarriers for lung drug delivery","volume":"10","author":"Pontes","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.cbi.2022.110048_bib21","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2022.110048_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2021.110680","article-title":"Mucus targeting as a plausible approach to improve lung function in COVID-19 patients","volume":"156","author":"Kumar","year":"2021","journal-title":"Med. Hyp"},{"key":"10.1016\/j.cbi.2022.110048_bib23","article-title":"Abnormal airway mucus secretion induced by virus infection","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2022.110048_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.n436","article-title":"Severe COVID19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cbi.2022.110048_bib25","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2021-0287","article-title":"Mucoadhesive nanoformulations and their potential for combating COVID19","author":"Prasher","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cbi.2022.110048_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/md18120605","article-title":"The application of mucoadhesive chitosan nanoparticles in nasal drug delivery","volume":"18","author":"Shim","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.cbi.2022.110048_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2016.12.023","article-title":"Acrylated chitosan for mucoadhesive drug delivery systems","volume":"517","author":"Shitrit","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.carbpol.2017.03.019","article-title":"Thiolated chitosan micelles: highly mucoadhesive drug carriers","volume":"167","author":"Mahmood","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.cbi.2022.110048_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijbiomac.2016.05.054","article-title":"Why Chitosan? from properties to perspective of mucosal drug delivery","volume":"91","author":"Kumar","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cbi.2022.110048_bib30","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.3390\/ijms21186617","article-title":"Quaternary ammonium chitosans: the importance of the positive fixed change of the drug delivery systems","volume":"21","author":"Fabiano","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijbiomac.2020.09.163","article-title":"Mannose-anchored N,N,N,-trimethyl chitosan nanoparticles for pulmonary administration of Etofylline","volume":"165","author":"Pardeshi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cbi.2022.110048_bib32","first-page":"552","article-title":"Cyclosporine A\/porous quaternized chitosan microspheres as a novel drug delivery system, Artif. Cells Nanomed","volume":"46","author":"Yang","year":"2018","journal-title":"Biotechnol."},{"key":"10.1016\/j.cbi.2022.110048_bib33","first-page":"310","article-title":"Pharmacokinetics of etofylline after intravenous and oral administration to humans","volume":"19","author":"Zuidema","year":"1981","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.cbi.2022.110048_bib34","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/IAI.72.6.3147-3160.2004","article-title":"Pneumocystis activates human alveolar macrophage NF-\u03baB signaling through mannose receptors","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cbi.2022.110048_bib35","article-title":"Mannose and mannose-6-phosphate receptor-targeted drug delivery systems and their application in cancer therapy","volume":"7","author":"Vedove","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.cbi.2022.110048_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jconrel.2004.10.010","article-title":"Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions","volume":"102","author":"Yamamoto","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.cbi.2022.110048_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.cbi.2022.110048_bib38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/ajrccm.153.2.8564089","article-title":"Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma","volume":"153","author":"Lock","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2022.110048_bib40","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.4049\/jimmunol.1001707","article-title":"A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation","volume":"185","author":"Balsley","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cbi.2022.110048_bib41","first-page":"522","volume":"vol. 77","author":"Coren","year":"1997"},{"key":"10.1016\/j.cbi.2022.110048_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijpharm.2017.11.071","article-title":"Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis","volume":"536","author":"Vieira","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib43","first-page":"32","volume":"vol. 4","author":"Callado-Gonzalez","year":"2019"},{"key":"10.1016\/j.cbi.2022.110048_bib44","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1080\/21691401.2016.1260578","article-title":"Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung-cancer therapeutics","volume":"45","author":"Wang","year":"2017","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"key":"10.1016\/j.cbi.2022.110048_bib45","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20457","article-title":"Folate receptor-mediated drug targeting: from therapeutics to diagnostics","volume":"94","author":"Hilgenbrink","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.cbi.2022.110048_bib47","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acs.biomac.9b01665","article-title":"Diaminated starch: a competitor of chitosan with highly mucoadhesive properties due to increased local cationic charge density","volume":"21","author":"Nouri","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.cbi.2022.110048_bib48","doi-asserted-by":"crossref","first-page":"118664","DOI":"10.1016\/j.ijpharm.2019.118664","article-title":"Cationic starch derivatives as mucoadhesive and soluble excipients in drug delivery","volume":"570","author":"Jelkmann","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4333\/KPS.2010.40.S.033","article-title":"Hyaluronic acid in drug delivery systems","volume":"40","author":"Jin","year":"2010","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.cbi.2022.110048_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/polym10030243","article-title":"Thiolated hyaluronic acid as versatile mucoadhesive polymer: from the chemistry behind to product developments-what are the capabilities?","volume":"10","author":"Griesser","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.cbi.2022.110048_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijpharm.2007.04.019","article-title":"Synthesis and in vitro analysis of thiolated hyaluronic acid for mucoadhesive drug delivery","volume":"343","author":"Kafedjiiski","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1517\/14656566.2011.571210","article-title":"(R)-salbutamol in the treatment of asthma and chronic obstructive airways disease","volume":"12","author":"Patel","year":"2011","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2022.110048_bib53","doi-asserted-by":"crossref","first-page":"A74","DOI":"10.1186\/1824-7288-41-S2-A74","article-title":"Salbutamol and around","volume":"41","author":"Ullmann","year":"2015","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.cbi.2022.110048_bib54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0735-6757(96)90121-7","article-title":"Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels","volume":"14","author":"Rodrigo","year":"1996","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cbi.2022.110048_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000194607","article-title":"Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis","volume":"45","author":"Lafortuna","year":"1984","journal-title":"Respiration"},{"key":"10.1016\/j.cbi.2022.110048_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.carbpol.2017.05.020","article-title":"Inhaled hyaluronic acid microparticles extended pulmonary retention and suppressed systemic exposure of a short-acting bronchodilator","volume":"172","author":"Li","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.cbi.2022.110048_bib57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/polym10070701","article-title":"Hyaluronic acid in the third millennium","volume":"10","author":"Fallacara","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.cbi.2022.110048_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1753465812458984","article-title":"Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study","volume":"6","author":"Furnari","year":"2012","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.cbi.2022.110048_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejps.2018.04.042","article-title":"Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: an in vitro study","volume":"120","author":"Fallacara","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib60","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.xphs.2019.04.015","article-title":"Co-spray-dried urea-cross-linked hyaluronic acid and sodium ascorbyl phosphate as novel inhalable dry powder formulation","volume":"108","author":"Fallacara","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2006.11.066","article-title":"Controlled drug delivery to the lung: influence of hyaluronic acid solution conformation on its adsorption to hydrophobic drug particles","volume":"330","author":"Rouse","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib62","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2174\/1381612825666190425163424","article-title":"Alginate nanoparticles for drug delivery and targeting","volume":"25","author":"Severino","year":"2019","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.cbi.2022.110048_bib63","doi-asserted-by":"crossref","first-page":"20267","DOI":"10.1039\/D0NJ04612D","article-title":"Mucoadhesive alginate synthesis: a multivariate calibration approach","volume":"44","author":"Navarro","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.cbi.2022.110048_bib64","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4103\/0250-474X.84590","article-title":"Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties","volume":"72","author":"Jindal","year":"2010","journal-title":"Indian, J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2009.01.029","article-title":"Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate","volume":"136","author":"Davidovich-Pinhas","year":"2009","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.cbi.2022.110048_bib66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.actbio.2010.09.021","article-title":"Alginate-PEGAc: a new mucoadhesive polymer","volume":"7","author":"Pinhas","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.cbi.2022.110048_bib67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfb.2012.02.030","article-title":"Preparation and characterization of rifampicin-PLGA microspheres\/sodium alginate in situ gel combination delivery system","volume":"95","author":"Hu","year":"2012","journal-title":"Colloid Surf. B."},{"key":"10.1016\/j.cbi.2022.110048_bib68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1120009X.2015.1105624","article-title":"Non-invasive endotracheal delivery of paclitaxel-loaded alginate microparticles","volume":"28","author":"Alipour","year":"2016","journal-title":"J. Chemother."},{"key":"10.1016\/j.cbi.2022.110048_bib69","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cbi.2022.110048_bib70","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2217\/nnm-2017-0072","article-title":"Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment","volume":"12","author":"Amore","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cbi.2022.110048_bib71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2019.03.059","article-title":"Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment","volume":"562","author":"Amore","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105955","article-title":"Engineered mucoadhesive microparticles of formoterol\/budesonide for pulmonary administration","volume":"165","author":"Monou","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116978","article-title":"Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages","volume":"252","author":"Vieira","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.cbi.2022.110048_bib74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijpharm.2017.11.071","article-title":"Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis","volume":"536","author":"Vieira","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acs.molpharmaceut.7b00846","article-title":"New folate-grafted chitosan derivative to improve delivery of paclitaxel-loaded solid lipid nanoparticles for lung tumor therapy by inhalation","volume":"15","author":"Rosiere","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2017.12.017","article-title":"Mucus penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: proof of concept, challenges and pitfalls","volume":"124","author":"Nafee","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2017.05.013","article-title":"Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis","volume":"527","author":"Torge","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpb.2020.01.017","article-title":"Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer","volume":"149","author":"Alp","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib79","article-title":"Recent advances in inhalable liposomes for treatment of pulmonary fibrosis concept to clinical stance","volume":"56","author":"Mehta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.cbi.2022.110048_bib80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ejpb.2007.04.005","article-title":"Liposomes for drug delivery to the lungs by nebulization","volume":"67","author":"Zaru","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib81","first-page":"1139","article-title":"Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery","volume":"7","author":"Chen","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2022.110048_bib82","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/PL00022055","article-title":"Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability","volume":"24","author":"Kleemann","year":"2007","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.cbi.2022.110048_bib83","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10611860902795407","article-title":"Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation","volume":"17","author":"Zhang","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.cbi.2022.110048_bib84","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/acs.molpharmaceut.8b01256","article-title":"Tailored nanocarriers for the pulmonary delivery of levofloxacin against Pseudomonas aeruginosa: a comparative study","volume":"16","author":"Derbali","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib85","first-page":"91","article-title":"Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis","volume":"13","author":"Chennakesavulu","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib86","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijbiomac.2019.11.190","article-title":"Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine","volume":"156","author":"Hamedinasab","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cbi.2022.110048_bib87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2017.04.044","article-title":"Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin","volume":"525","author":"Manconi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib88","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2016.11.025","article-title":"Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate","volume":"151","author":"Triolo","year":"2017","journal-title":"Colloid. Surf. B."},{"key":"10.1016\/j.cbi.2022.110048_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2018.06.006","article-title":"In vitro\/in vivo investigation on the potential of pluronic mixed micelles for pulmonary drug delivery","volume":"130","author":"Pellosi","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2018.10.098","article-title":"Mucoadhesive guargum hydrogel inter-connected chitosan-g-polycaprolactone micelles for rifampicin delivery","volume":"206","author":"Yuan","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.cbi.2022.110048_bib91","article-title":"Pulmonary delivery of rifampicin-loaded soluplus micelles against Mycobacterium tuberculosis","volume":"53","author":"Grotz","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.cbi.2022.110048_bib92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2019.01.022","article-title":"Drug delivery of rifampicin by natural micelles based on inulin: physicochemical properties, antibacterial activity and human macrophages uptake","volume":"136","author":"Tripodo","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100110","article-title":"Engineering nanoparticles to overcome the mucus barrier for drug delivery: design, evaluation and state-of-the-art","author":"Liu","year":"2021","journal-title":"Medicine Drug Disc"},{"key":"10.1016\/j.cbi.2022.110048_bib94","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2022.110048_bib95","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1021\/acs.molpharmaceut.7b00584","article-title":"Nanoparticles of pH-responsive, PEG\u2013Doxorubicin conjugates: interaction with an in vitro model of lung adenocarcinoma and their direct formulation in propellant-based portable inhalers","volume":"14","author":"Rao","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib96","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jor1010002","article-title":"Observations of, and insights into, cystic fibrosis mucus heterogeneity in the pre-modulator era: sputum characteristics, DNA and glycoprotein content, and solubilization time","volume":"1","author":"Chance","year":"2021","journal-title":"J. Respiration (MDPI)."},{"key":"10.1016\/j.cbi.2022.110048_bib97","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.molpharmaceut.8b00011","article-title":"PEGylation of tobramycin improves mucus penetration and antimicrobial activity against Pseudomonas aeruginosa biofilms in vitro","volume":"15","author":"Bahamondez-Canas","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib98","article-title":"PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection","volume":"23","author":"Constabile","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.cbi.2022.110048_bib99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.cbi.2022.110048_bib100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0885328219863291","article-title":"Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs","volume":"34","author":"Almeida","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.cbi.2022.110048_bib101","article-title":"PEGylated green halloysite\/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: a potential pulmonary drug-delivery treatment option for COVID-19","author":"Jermy","year":"2021","journal-title":"Appl. Clay Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2466-14-56","article-title":"Real-life use of fluticasone propionate\/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study","volume":"14","author":"Roche","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cbi.2022.110048_bib103","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2016.02.031","article-title":"Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles","volume":"502","author":"Popov","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2020.03.032","article-title":"Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery","volume":"322","author":"Leal","year":"2020","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.cbi.2022.110048_bib105","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.apsb.2019.10.002","article-title":"Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein","volume":"10","author":"Dong","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.cbi.2022.110048_bib106","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.addr.2019.04.007","article-title":"Thiolated polymers: bioinspired polymers utilizing one of the most important bridging structures in nature","volume":"151\u2013152","author":"Leichner","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2022.110048_bib107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2015.11.037","article-title":"Preactivated thiolated nanoparticles: a novel, mucoadhesive dosage form","volume":"497","author":"Menzel","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103321","article-title":"Design of mannose-coated rifampicin nanoparticles modulating the immune response and rifampicin induced hepatotoxicity with improved oral drug delivery","volume":"14","author":"Rauf","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.cbi.2022.110048_bib109","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.ijbiomac.2020.10.192","article-title":"Aerodynamic properties and in silico deposition of isoniazid loaded chitosan\/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment","volume":"165","author":"Mukhtar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cbi.2022.110048_bib110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpb.2017.06.011","article-title":"Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery","volume":"119","author":"Perrone","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.cbi.2022.110048_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119371","article-title":"Synthesis and in vitro characterization of a preactivated thiolated acrylic acid\/acrylamide-methylpropane sulfonic acid copolymer as a mucoadhesive sprayable polymer","volume":"583","author":"Prufert","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2022.110048_bib112","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejps.2016.09.031","article-title":"Enhancing the efficiency of thiomers: utilizing a highly mucoadhesive polymer as backbone for thiolation and preactivation","volume":"96","author":"Prufert","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2022.110048_bib113","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomater"},{"key":"10.1016\/j.cbi.2022.110048_bib114","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cbi.2022.110048_bib115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(98)06532-5","article-title":"Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial","volume":"353","author":"Alton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.110048_bib116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10020-020-00215-w","article-title":"Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series","volume":"26","author":"Weber","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2022.110048_bib117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2014.11.022","article-title":"Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase)","volume":"198","author":"Deacon","year":"2015","journal-title":"J. Contr. Release"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:11:18Z","timestamp":1757859078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722002538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":117,"alternative-id":["S0009279722002538"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110048","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110048"}}